This article documents the clinical course of nine @entity1 diagnosed as having @entity5 ( @entity5 ). Five @entity1 had a history of @entity1593 . This @entity5 commonly affects the small bowel in a widespread, patchy fashion causing ulceration, stricture formation, and perforation. @entity3 to mesenteric nodes, liver, and the bone marrow were common. Although the diagnosis of @entity5 was often made at laparotomy, surgical resection, even when extensive, was not curative in any case. All nine @entity1 were treated with a variety of chemotherapeutic regimes. This @entity5 proved chemosensitive, although response was usually brief and difficult to accurately evaluate. Chemotherapy was poorly tolerated because these @entity1 were malnourished. In two cases small bowel perforation occurred, and in one @entity360 occurred after chemotherapy. Eight @entity1 have died of disease from 0 to 16 months after the diagnosis was made, and a single @entity1 is apparently cured 5+ years after completing chemotherapy. Malignant histiocytosis of the intestine has a characteristic clinical course. It is hoped that increased clinical awareness and early diagnosis will improve the outcome.

Clinical features and management of XXXX .

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity1593 :: ('MESH:D002446', 'Disease') :: ['gluten-sensitive enteropathy'] @entity5 :: ('MESH:D009369', 'Disease') :: ['tumor', 'MHI', 'malignant histiocytosis of the intestine'] @entity3 :: ('MESH:D009362', 'Disease') :: ['Metastases'] @entity360 :: ('MESH:D006471', 'Disease') :: ['gastrointestinal bleeding']
@entity5 :: (MESH:D009369,Disease) :: ['malignant histiocytosis of the intestine']
